MOR00208: Phase II started

MorphoSys began the open-label, international Phase II L-MIND trial to evaluate 12 mg/kg IV

Read the full 143 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE